Actively Recruiting
Longitudinal Study of Patients With SARS-CoV-2 Infection and Long COVID Symptoms
Led by University of North Carolina, Chapel Hill · Updated on 2026-09-28
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to understand how common Long COVID is and how symptoms persist over time in people who have had COVID-19. It focuses on individuals with past SARS-CoV-2 infection to study the ongoing or new symptoms that may last more than two years. The study seeks to identify demographic, clinical, and biological factors linked to these persistent symptoms. Participants will provide health information through questionnaires and saliva samples for biological analysis. The saliva will be tested for proteins, metabolites, microorganisms, and immune-related markers that might be associated with Long COVID. Machine learning will be used to analyze combined data from demographics, symptoms, and saliva to find patterns that predict who may experience persistent or severe symptoms. Participants will complete health surveys and provide saliva samples during the study. Researchers will monitor symptom burden and biological markers from active infection through three months post infection using validated questionnaires. The study aims to improve understanding of Long COVID and identify factors that contribute to lasting symptoms, with participation lasting up to five years from the study start in 2024 through 2029.
CONDITIONS
Brief Title
Long-Term Study of COVID-19 Infection and Long COVID
Research Team
L
Laura A Jacox, PhD, DMD, MS
J
Jeannene L Matthews, MA, M.Ed., CCC-SLP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here